Susan E. Moody, Ph.D. - Publications

Affiliations: 
2003 University of Pennsylvania, Philadelphia, PA, United States 
Area:
Molecular Biology, Oncology

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Ruth JR, Pant DK, Pan TC, Seidel HE, Baksh SC, Keister BA, Singh R, Sterner CJ, Bakewell SJ, Moody SE, Belka GK, Chodosh LA. Cellular dormancy in minimal residual disease following targeted therapy. Breast Cancer Research : Bcr. 23: 63. PMID 34088357 DOI: 10.1186/s13058-021-01416-9  0.621
2019 Hao HX, Wang H, Liu C, Kovats S, Velazquez R, Lu H, Pant B, Shirley M, Meyer MJ, Pu M, Lim J, Fleming M, Alexander L, Farsidjani A, LaMarche MJ, ... Moody S, et al. Tumor intrinsic efficacy by SHP2 and RTK inhibitors in KRAS mutant cancers. Molecular Cancer Therapeutics. PMID 31439712 DOI: 10.1158/1535-7163.Mct-19-0170  0.345
2019 Lu H, Liu C, Velazquez R, Wang H, Dunkl LM, Kazic-Legueux M, Haberkorn A, Billy E, Manchado E, Brachmann SM, Moody S, Engelman JA, Hammerman PS, Caponigro G, Mohseni M, et al. Abstract 954: SHP2 inhibition overcomes RTK-mediated pathway reactivation in KRAS mutant tumors treated with MEK inhibitors Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-954  0.416
2008 Debies MT, Gestl SA, Mathers JL, Mikse OR, Leonard TL, Moody SE, Chodosh LA, Cardiff RD, Gunther EJ. Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss. The Journal of Clinical Investigation. 118: 51-63. PMID 18060046 DOI: 10.1172/Jci33320  0.696
2007 Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nature Cell Biology. 9: 493-505. PMID 17450133 DOI: 10.1038/Ncb1567  0.676
2006 Hayworth CR, Moody SE, Chodosh LA, Krieg P, Rimer M, Thompson WJ. Induction of neuregulin signaling in mouse schwann cells in vivo mimics responses to denervation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 6873-84. PMID 16793894 DOI: 10.1523/Jneurosci.1086-06.2006  0.518
2006 Blakely CM, Stoddard AJ, Belka GK, Dugan KD, Notarfrancesco KL, Moody SE, D'Cruz CM, Chodosh LA. Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy. Cancer Research. 66: 6421-31. PMID 16778221 DOI: 10.1158/0008-5472.Can-05-4235  0.769
2006 Ponomareva ON, Ma H, Vock VM, Ellerton EL, Moody SE, Dakour R, Chodosh LA, Rimer M. Defective neuromuscular synaptogenesis in mice expressing constitutively active ErbB2 in skeletal muscle fibers. Molecular and Cellular Neurosciences. 31: 334-45. PMID 16278083 DOI: 10.1016/J.Mcn.2005.10.004  0.563
2005 Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ, Notorfrancesco KL, Cardiff RD, Chodosh LA. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell. 8: 197-209. PMID 16169465 DOI: 10.1016/J.Ccr.2005.07.009  0.782
2005 Blakely C, Moody S, Stoddard A, Tombler E, Liu C, Chodosh L. Molecular approaches to understanding pregnancy-induced protection against breast cancer Breast Cancer Research. 7: 1-1. DOI: 10.1186/Bcr1055  0.752
2004 Muraoka-Cook RS, Kurokawa H, Koh Y, Forbes JT, Roebuck LR, Barcellos-Hoff MH, Moody SE, Chodosh LA, Arteaga CL. Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors. Cancer Research. 64: 9002-11. PMID 15604265 DOI: 10.1158/0008-5472.Can-04-2111  0.621
2003 Gunther EJ, Moody SE, Belka GK, Hahn KT, Innocent N, Dugan KD, Cardiff RD, Chodosh LA. Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes & Development. 17: 488-501. PMID 12600942 DOI: 10.1101/Gad.1051603  0.678
2003 Chodosh L, Boxer R, Moody S, Keister B, Sarkisian C, Jang J, Belka G, Blakely C, Portocarero C, Sterner C, Notarfrancesco K, Kauh E. Reversibility and progression in conditional transgenic mouse models of breast cancer Breast Cancer Research. 5: 5-5. DOI: 10.1186/Bcr664  0.726
2002 Moody SE, Sarkisian CJ, Hahn KT, Gunther EJ, Pickup S, Dugan KD, Innocent N, Cardiff RD, Schnall MD, Chodosh LA. Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell. 2: 451-61. PMID 12498714 DOI: 10.1016/S1535-6108(02)00212-X  0.776
2002 D'Cruz CM, Moody SE, Master SR, Hartman JL, Keiper EA, Imielinski MB, Cox JD, Wang JY, Ha SI, Keister BA, Chodosh LA. Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland. Molecular Endocrinology (Baltimore, Md.). 16: 2034-51. PMID 12198241 DOI: 10.1210/Me.2002-0073  0.768
2002 Master SR, Hartman JL, D'Cruz CM, Moody SE, Keiper EA, Ha SI, Cox JD, Belka GK, Chodosh LA. Functional microarray analysis of mammary organogenesis reveals a developmental role in adaptive thermogenesis. Molecular Endocrinology (Baltimore, Md.). 16: 1185-203. PMID 12040007 DOI: 10.1210/Mend.16.6.0865  0.737
2001 D'Cruz CM, Gunther EJ, Boxer RB, Hartman JL, Sintasath L, Moody SE, Cox JD, Ha SI, Belka GK, Golant A, Cardiff RD, Chodosh LA. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nature Medicine. 7: 235-9. PMID 11175856 DOI: 10.1038/84691  0.773
2001 Master S, Hartman J, Stoddard A, Keiper E, Moody S, D’Cruz C, Chodosh L. Functional analysis of mammary development using oligonucleotide microarrays Nature Genetics. 27: 47. DOI: 10.1038/87036  0.677
Show low-probability matches.